# EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)

> **NCT05735912** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Azienda Ospedaliera Universitaria Integrata Verona** · enrollment: 60 (estimated)

## Conditions studied

- Pancreatic Insulinoma

## Interventions

- **PROCEDURE:** Endoscopic ultrasound-guided radio frequency ablation
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT05735912
- **Lead sponsor:** Azienda Ospedaliera Universitaria Integrata Verona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2028-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05735912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05735912, "EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05735912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*